For a number of years it has been well established that human Cytomegalovirus (HCMV)
can be transmitted by the cellular components of blood. HCMV is also associated with a …

Clinical experience and laboratory data suggest that human cytomegalovirus (HCMV) is
present in peripheral blood of seropositive individuals in a latent or persistent state and can …

The susceptibility of hematopoietic progenitor cells to infection by human cytomegalovirus
(HCMV) was investigated using several strains of HCMV, including the recombinant strain …

We successfully infected fluorescence-activated cell-sorted CD34+ cells from normal cord
blood by the human cytomegalovirus (HCMV) laboratory strain Towne. An inhibitory effect of …

As an attempt to elucidate further the pathogenesis of human cytomegalovirus (HCMV)
infection the replication of HCMV in primary human bone marrow cells (BMC) has been …

Human cytomegalovirus (HCMV) resides latently in hematopoietic cells of the bone marrow.
Although viral genomes can be found in CD14+ monocytes and CD34+ progenitor cells, the …

The human cytomegalovirus (HCMV) is a major pathogen in immunocompromised patients.
Both, primary infection and reactivation of latent virus can cause disease. Peripheral blood …

Bone marrow suppression with leukopenia is frequently observed during human
cytomegalovirus (HCMV) infection, and in vitro the cell colony formation of bone marrow …

The cellular sites and mechanisms of human cytomegalovirus (HCMV) latency are still
poorly defined. Although evidence suggests that peripheral blood monocytes are one site of …

Peripheral blood monocytes (PBM) are one site of persistence of human cytomegalovirus
(HCMV) in healthy carriers. However, because PBM circulate only briefly before entering the …